The benefits of GLP-1 drugs beyond obesity. science.org/doi/10.1126/sc…

The actions of GLP-1 medications. science.org/doi/10.1126/sc…

This meta-analysis of 12 RCTs found that the effects of SGLT2 inhibitors on cardiovascular and kidney outcomes are consistent regardless of background use of GLP-1 RAs. thelancet.com/journals/landi…

Systematic review and meta-analysis on the effects of intermittent fasting on body composition and cardiometabolic health in adults with prediabetes or type 2 diabetes. Intermittent fasting was more effective than calorie restriction for weight loss but not for reducing fat mass,

Fast eating is a bad habit that can increase the risk for #MASLD. nature.com/articles/s4138…

My thoughts on how to get rid of #menopausebelly. honehealth.com/edge/how-to-ge…

Patients with type 2 diabetes have higher liver stiffness and fat fraction compared with those with type 1 diabetes. Even after adjusting for sex, BMI, and diabetes duration, liver stiffness was 5 times higher in patients with T2D. …ubs.pericles-prod.literatumonline.com/doi/10.1111/do…

Diabetes meal planning starts with just one small step, then build on it. ajc.com/things-to-do/a…

People with PCOS have a higher risk of type 2 diabetes, hypertension, hepatocellular carcinoma, and depression or anxiety compared with controls. They also have a higher risk for cardiovascular disease, hepatic steatosis, and hepatic fibro-inflammation. academic.oup.com/jcem/advance-a…

Regulation and functional significance of the cortisol awakening response. academic.oup.com/edrv/advance-a…

This study compared medication adherence to SGLT2 inhibitors and GLP-1 receptor agonists through a meta-analysis. In all studies, no difference in nonadherence was found between the two medications. However, in studies conducted in the US, SGLT2 inhibitor use was associated with

Strength and endurance training can be effective in reducing visceral fat volume and body weight. …ubs.pericles-prod.literatumonline.com/doi/10.1111/do…

This study evaluated the efficacy and safety of GLP-1 receptor agonists and SGLT2 inhibitors, in liver transplant recipients with diabetes. The results showed improvements in weight/BMI and A1c levels for both medication groups. …ubs.pericles-prod.literatumonline.com/doi/epdf/10.11…

This is a nice review of the role of incretin receptor agonists in the treatment of obesity. …ubs.pericles-prod.literatumonline.com/doi/epdf/10.11…

The metabolically healthy obesity phenotype is a dynamic status over time and can convert to metabolically unhealthy increasing the risk of colorectal cancer. onlinelibrary.wiley.com/doi/abs/10.100…

Chiglitazar, a pan-PPAR agonist ameliorates #MASLD by modulating multiple pathways. pubmed.ncbi.nlm.nih.gov/39098464/

We must address the #MASLD awareness gap, improve educational quality and prepare for the digitally quantified self. Jeffrey V. Lazarus onlinelibrary.wiley.com/doi/epdf/10.11…

MASLD and MASH require urgent attention by primary care physicians and endocrinologists. pubmed.ncbi.nlm.nih.gov/38735676/

In the liver-heart-kidney-metabolic axis, the common pathophysiological basis of #MASLD, cardiovascular disease, chronic kidney disease, and type 2 diabetes is the same. #CVD #CKD #diabetes #MASH pubmed.ncbi.nlm.nih.gov/38565488/

Molecular mechanisms involved in the metabolic heart-liver-kidney axis. pubmed.ncbi.nlm.nih.gov/38565488/